ARCHIVES

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

September 17, 2010

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

NCI blocked groups from phase III Iressa studies.

April 30, 2004

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

June 2, 1995